Should Morgan Stanley (MS) Be Allowed To Repay TARP?

According to CNBC's Charlie Gasparino, Morgan Stanley (NYSE: MS) has sought preliminary approval to repay TARP. Should they be approved?

Based on the results of the recent stress tests, Morgan Stanley had a capital buffer shortfall of $1.8 billion. Morgan Stanley recently bolstered its capital base by $8 billion from selling common shares and debt.

So based on this, the company has more than covered the $1.8 billion capital buffer shortfall, but by repaying its $10 billion in TARP this may put the company back in the grey area. It is not clear if they will or should get the approval.

You May Also Be Interested In

• Anthropic Pursues First Data Center Leases - Information
• Morgan Stanley: 'What GOOGL Home Listing Ads Mean for Zillow', 'the Long-Term Risks Are Real'
• Morgan Stanley Upgrades Towa Pharmaceutical Co Ltd (4553:JP) to Overweight